Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) has been assigned a consensus recommendation of “Buy” from the ten research firms that are covering the firm, MarketBeat reports. Ten equities research analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have issued a report on the stock […]
Pacira BioSciences (NASDAQ:PCRX) Coverage Initiated by Analysts at JPMorgan Chase & Co themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Pacira BioSciences, Inc (NASDAQ:PCRX) Director Gary W Pace Sells 90,000 Shares theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Gotham Asset Management LLC boosted its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 16.8% in the third quarter, Holdings Channel.com reports. The institutional investor owned 22,317 shares of the company’s stock after acquiring an additional 3,203 shares during the period. Gotham Asset Management LLC’s holdings in Pacira BioSciences were worth […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) – Zacks Research dropped their Q1 2025 earnings estimates for Pacira BioSciences in a research report issued to clients and investors on Friday, February 23rd. Zacks Research analyst R. Department now expects that the company will post earnings of $0.69 per share for the quarter, down from their […]